Major goals for this project are to establish the roles of Ang II and Na in resetting of the arterial baroreflex (ABR) in AngII-induced hypertension. Experiments will determine the integrative roles of the area postrema (AP), the paraventricular nucleus (PVN), and hepatoportal osmo/Na receptors in ABR resetting and the accompanying HT. The hypotheses to be tested are (1) HT due to low dose infusions of Ang II and NaCl involves an upward resetting of the ABR and (2) Converging projections from the AP, PVN, and hepatoportal osmo/Na receptors within the NTS determine the integrative neuronal response to baroreceptor afferent input. Both the resetting and changes in NTS neuronal responses involve activation in the AP and PVN. Activity within the AP is due to circulating Ang II, while the PVN is sensitive to Na. When Na is increased, hepatoportal reflexes will oppose ABR resetting and the Ang II-induced HT. To test these hypotheses, the combined and separate roles of AngII and Na on ABR control of RSNA, MAP and HT will be determined in conscious rats. Hepatoportal denervation, lesioning and AT1 receptor blockade of the AP and PVN, and selective activation of afferents in the three regions will be determined. One goal is to determine if AP and PVN inputs attenuate NTS neuronal responses to baroreceptor afferent inputs. Other goals are to determine if hepatoportal afferents facilitate baroreceptor-evoked single unit discharge, thereby opposing the inhibitory influence of AP and PVN inputs. Proposed studies are unique in that they are the first to investigate potential interactions between the brainstem (AP), descending hypothalamic (PVN) and ascending peripheral afferent (hepatoportal) inputs on the reflex regulation of sympathetic outflow and arterial pressure. Proposed studies will build upon our understanding of how circulating factors can influence the ABR and will provide a foundation for future studies to determine the specific neurotransmitter mechanisms that are active in modulating ABR function in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059326-03
Application #
6125851
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1997-12-19
Project End
2001-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
3
Fiscal Year
2000
Total Cost
$172,692
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Physiology
Type
Other Domestic Higher Education
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
LaGrange, Lila P; Toney, Glenn M; Bishop, Vernon S (2003) Chronic angiotensin II infusion attenuates the renal sympathoinhibitory response to acute volume expansion. Am J Physiol Regul Integr Comp Physiol 284:R1098-107
LaGrange, Lila P; Toney, Glenn M; Bishop, Vernon S (2003) Effect of intravenous angiotensin II infusion on responses to hypothalamic PVN injection of bicuculline. Hypertension 42:1124-9
Sanderford, Max G; Bishop, Vernon S (2002) Central mechanisms of acute ANG II modulation of arterial baroreflex control of renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 282:H1592-602
Sanderford, M G; Bishop, V S (2000) Angiotensin II acutely attenuates range of arterial baroreflex control of renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 279:H1804-12